Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis. - Wikidata - wikimedia - TriplyDB

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

http://www.wikidata.org/entity/Q40258614

about

Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases.Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 mutations in thyroid cancers.RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.Absence of common activating mutations of the epidermal growth factor receptor gene in thyroid cancers from American and Japanese patients.Thyroid cancer: pathogenesis and targeted therapy New perspectives on the treatment of differentiated thyroid cancer.Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer.New agents in the treatment for malignancies of the salivary and thyroid glands.Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.Anaplastic thyroid cancer: a comprehensive review of novel therapy.Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.RET TKI: potential role in thyroid cancers.Emerging therapies: angiogenesis inhibitors for ovarian cancer.DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer.Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma.A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma.Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma.CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.

P2860

Q33984845-C1FB298F-B6F8-43E1-9489-A1810C7FB30A Q33998155-EC7D74A2-6823-4E17-837D-C7A1CAF7DA93 Q35058437-E886E354-C59A-4E61-8655-7929BD5D47AD Q35097324-3FD9342C-29C0-46E3-BB11-1F81E1FD6937 Q35124840-94E39C0F-3B25-46AF-B7ED-B9146172D257 Q35748487-AF82E640-7CC6-4FFA-AE21-AADA4E4E73F3 Q36328045-8F64CD33-4475-4B19-AB6B-910D98C5B49A Q36904500-99FD1E78-CF36-4345-9ED6-8970F4CAD440 Q36949801-3AF75E7B-3894-4442-8E3C-68B1FDA9627E Q37137859-086C2F75-1A5C-480D-AE4C-A33BD4289553 Q37628964-846B47E5-3183-4209-868E-25262CCDD124 Q37854708-50FADC5B-6323-4DEB-8FF0-92B69FF91B67 Q37959101-154B9F4F-84C0-42E3-88BB-BB2B447A93A7 Q37979656-28DA377D-CAFD-42BF-9177-26B18683926B Q38497958-73C4751F-2DD8-4204-B8A1-B37264CCC328 Q39890321-B854B0DF-C62D-4F77-90B8-EDE163BCD9A8 Q41251561-950B87DF-D33B-4E6E-9A34-44B05E803639 Q42180596-1F2DEFF7-9053-4B00-8E37-DF0214B9F211 Q44051250-9C7AF2A7-EC98-4CAE-884B-425683D95A15 Q45277681-4B860B76-07EB-4644-BC62-DB6081DCE447 Q54578719-59C05E54-AE4A-441A-930C-DEC1239804A2 Q55362221-26676DE3-BC9A-48F6-AF3A-ACCC8F32E168

P2860

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

http://www.wikidata.org/entity/Q40258614

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Epidermal growth factor recept ...... ional and functional analysis.

@en

type

label

Epidermal growth factor recept ...... ional and functional analysis.

@en

prefLabel

Epidermal growth factor recept ...... ional and functional analysis.

@en

P1433

Q40258614-142B3D6E-31B1-4B31-B94F-60DD4F911CE6

P1476

Q40258614-DAA7DFAC-4E8C-4658-93FE-7D89FD9C3F31

P2093

Q40258614-0F2F6D51-026A-4ABB-BE2D-CB2605077F9D

Q40258614-21D1D654-FBA9-429F-B8D3-AEE8B5BF1F71

Q40258614-307BE545-011A-47DF-A07D-AD7DEAEAD366

Q40258614-6DA7C480-8AED-4075-8773-D1020A32AD5A

Q40258614-AC232C31-0091-48FE-AF9A-E0FE489CD9D5

Q40258614-B57C3F3E-99A3-435A-AC90-EF28B13F08C3

Q40258614-BDB5A259-7FDC-4E45-AD0D-8CB2C74443FB

Q40258614-E65A83CD-B7BD-4446-AC4D-D4C378FBD380

Q40258614-EDAA9872-8D1A-425F-8154-8F7141207606

P304

Q40258614-B9859055-AA66-4172-8F18-7C59107BC5B8

P31

Q40258614-AAA7DDC4-1284-45DB-BD01-D8D96498FDA4

P356

Q40258614-2F88ADAD-85DF-4BD8-806C-24A86CEBDDB6

P407

Q40258614-A333D347-715A-44BA-BF7A-8057CF1BCDD9

P433

Q40258614-A846FA61-8D74-490C-9C79-3CBA542B6F76

P478

Q40258614-2ACA62FE-8BD3-4719-A4A7-9122BB4A3D68

P50

Q40258614-DBF1B7CA-D2E0-4CCC-8031-9F2EA793754A

P577

Q40258614-A3D45CCF-C6B0-49E3-ADF0-ACC6B830D1EA

P698

Q40258614-E096CC64-F2F4-4594-98CB-DF55F85477B3

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Epidermal growth factor recept ...... tional and functional analysis

@en

P2093

Constantine S Mitsiades

http://www.w3.org/2001/XMLSchema#string

Elias Sozopoulos

http://www.w3.org/2001/XMLSchema#string

Elpida Charalambous

http://www.w3.org/2001/XMLSchema#string

Gerassimos Voutsinas

http://www.w3.org/2001/XMLSchema#string

Joseph Negri

http://www.w3.org/2001/XMLSchema#string

Nicholas Mitsiades

http://www.w3.org/2001/XMLSchema#string

Sophia Tseleni-Balafouta

http://www.w3.org/2001/XMLSchema#string

Vassiliki Kotoula

http://www.w3.org/2001/XMLSchema#string

Vassiliki Poulaki

http://www.w3.org/2001/XMLSchema#string

P304

3662-3666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2006-0055

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Galinos Fanourakis

P577

2006-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16822827

http://www.w3.org/2001/XMLSchema#string